Prevalence and associated factors of cardiovascular diseases among men and women aged 45 years and above: Analysis of the longitudinal ageing study in India, 2017–2019
“…These results did not suggest a definite association between PA and the reduced risk of stroke. However, previous studies 2–5 have consistently suggested that PA was associated with reduced risk of stroke. It would be helpful if the authors could give some explanations for this discrepancy.…”
“…These results did not suggest a definite association between PA and the reduced risk of stroke. However, previous studies 2–5 have consistently suggested that PA was associated with reduced risk of stroke. It would be helpful if the authors could give some explanations for this discrepancy.…”
“…The rise in India’s aging population 9 is primarily responsible for increased deaths due to ischemic heart disease and stroke. 10 As per the Trivandrum Stroke Registry, stroke patients living in rural areas are disadvantaged regarding optimal investigation and treatment compared to their urban counterparts. A comparison of stroke incidences between North and South India indicated that the traditional vascular risk factors are more prevalent in the South.…”
The stroke burden in India is alarmingly high compared to Western industrialised countries, necessitating immediate action to develop stroke systems of care. Tailored stroke-prevention strategies, adequate resource allocation for stroke management and research, and increased awareness of specialised care in acute Stroke are critical. The COVID-19 pandemic has underscored the need for improved healthcare delivery and infrastructure. To address the rising stroke burden in India, comprehensive strategies encompassing prevention, awareness, specialised care and governmental support are urgently required. While the concept of ‘stroke-ready centres’ has emerged, their limited availability hinders widespread benefits. This expert consensus examines the current state of stroke care in India, identifies challenges, and proposes strategies to enhance stroke care systems. It offers valuable insights into stroke management at different levels, empowering healthcare professionals and administrators to assess their existing systems and make necessary improvements. Special attention is given to the role of physicians, including the use of thrombolytic therapies like Tenecteplase, in reducing the stroke burden and improving outcomes across the country. Significant strides can be made in stroke management and care in India by addressing these critical areas.
“…India has witnessed an alarming increase in the incidence of stroke among younger individuals in recent years. 2 This shift can be attributed to a rising prevalence of risk factors such as hypertension, diabetes, and unhealthy lifestyles, including poor diet and physical inactivity. As of 2021, the estimated prevalence of stroke in India stood at approximately 119-145 cases per 100,000 populations, making it one of the highest in the world.…”
: Stroke is the leading cause of long-term disability and one of the top causes of mortality worldwide. The burden in India has been increasing at an alarming rate over the past few decades. India with its culturally diverse environment and economically developing status presents unique challenges in stroke management. This study is an initiative designed to gain a better understanding of stroke prevalence and therapy in India. : A cross-sectional questionnaire-based study among Indian Cardiologists was conducted. A convenient sampling method was used. About 34% of doctors said that acute stroke is most prevalent in the age group of 41- 50 years in their clinical setup. The study results also highlight that piracetam 800mg is the preferred effective option for age-related cognitive disorders. Some of them preferred Piracetam for vertigo of mixed origin, vestibular, and other associated disorders of vertiginous attacks. 51% of doctors observed that vertigo is diagnosed more frequently among both genders, more common in the age group of 21-30 years. 93% of doctors agreed that piracetam improves cognitive improvement post-surgery. Three-fourths of doctors who participated in the survey rated 45% of doctors prescribed the combination of piracetam and citicoline in post-stroke recovery patients. Also, 40% of them prescribed neuroprotective agents to 51-70% of stroke patients. This study demonstrated that the stroke prevalence rate is high among patients above 40 years of age. Piracetam 800 mg is commonly prescribed to most of the stroke patients. Half of the respondents felt that there was a significant improvement in cognitive decline with piracetam. This study's findings highlight that piracetam is an effective option for age-related cognitive disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.